diltiazem hydrochloride NDC 50742-251

Product information

Brand name (proprietary)

diltiazem hydrochloride

Generic name (nonproprietary)

diltiazem hydrochloride

Active ingredients

Diltiazem hydrochloride — 300 mg/1

Dosage form

Capsule, Extended release

Route

Oral

Labeler

Ingenus Pharmaceuticals, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 208783

Marketing start

Jun 14, 2019

Listing expires

Dec 31, 2026

Other FDA classes

Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)

Identifiers

Product ID 50742-251_d52d40db-f91a-49ea-ac2f-88a56f429421SPL ID d52d40db-f91a-49ea-ac2f-88a56f429421SPL set ID 355f560a-8ebb-4661-ad74-2a22f707d7f8RxCUI 830795, 830801, 830837, 830845, 830861UNII OLH94387TEUPC 0350742248308, 0350742249305, 0350742250301

Pharmacologic class

Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742025105 followed by a unit qualifier and the quantity Copy

Package 50742-0251-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 208783

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.